Schools Raise Record-Breaking Amount for Leukemia & Lymphoma Society

North American students participating in fundraising programs to benefit the Leukemia & Lymphoma Society in 2012 have entirely outdone themselves, breaking previous records for fundraising among School and Youth programs that have set the bar very high for years to come.

In all, over 27,000 schools and almost 16 million students in the United States and Canada participated in programs like Pennies for Patients and Pasta for Pennies during the 2012 school year. The funds collected are usually in the form of loose change, which makes their accomplishments all that more extraordinary.

To begin, Walter Johnson High School in Bethesda, Maryland became the top fundraiser in the nation for the LLS, raising an utterly astounding $59,029.54 through the Pennies for Patients program. Another Bethesda school wasn't far behind--Walt Whitman High raised $51,050.

Collectively, the 27,482 North American schools raised a record-shattering $28.7 million for the LLS, money which will support research into cancers that affect young people like leukemia and Hodgkin's lymphoma, as well as the LLS patient services program.

Source: LLS

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap